Iron Overload

• FDA label_change · 2020-07-23
  FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approves a supplemental application for JADENU (deferasirox) from Novartis, updating the product labeling.

• FDA label_change · 2018-05-11
  FDA Approved: EXJADE — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Exjade (deferasirox) submitted by Novartis to modify the labeling for the iron chelation therapy…

• FDA label_change · 2012-07-18
  FDA Approved: DEFEROXAMINE — Supplemental Application (Fresenius Kabi USA, LLC)

  FDA approved a supplemental application for Deferoxamine (Deferoxamine Mesylate) from Fresenius Kabi USA, LLC, likely involving changes to l…